How The OptimizeRx (OPRX) Narrative Is Shifting As Guidance Resets And Valuation Expectations Reprice [Yahoo! Finance]
OptimizeRx Corporation (OPRX)
NASDAQ:AMEX Investor Relations:
optimizerx.com/investors
Company Research
Source: Yahoo! Finance
The updated analyst work on OptimizeRx centers on a sharp reset in the stock's fair value estimate, with the price target revised from US$24.33 to US$14.50, a cut of roughly 40%. That shift lines up with Street commentary that balances solid Q4 revenue and EBITDA with lower 2026 revenue expectations and mixed views on pharma marketing budgets and policy headwinds. Read on to see how to track this evolving narrative and what to watch as new data points come through. Analyst Price Targets don't always capture the full story. Head over to our Company Report to find new ways to value OptimizeRx. What Wall Street Has Been Saying ?? Bullish Takeaways Lake Street keeps a Buy rating even after cutting its target to US$20 from US$24, highlighting improved profit forecasts and pointing to the new US$10m share repurchase authorization as potential support for the stock. Roth Capital maintains a Buy rating with its target reset to US$18 from US$32, citing already heavy valuation pressu
Show less
Read more
Impact Snapshot
Event Time:
OPRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OPRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OPRX alerts
High impacting OptimizeRx Corporation news events
Weekly update
A roundup of the hottest topics
OPRX
News
- OptimizeRx (OPRX) was upgraded by Zacks Research from "hold" to "strong-buy".MarketBeat
- OptimizeRx: Q4 Earnings Report Indicates Caution For 2026 [Seeking Alpha]Seeking Alpha
- OptimizeRx Corp (OPRX) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... [Yahoo! Finance]Yahoo! Finance
- OptimizeRx (OPRX) had its price target lowered by Lake Street Capital from $24.00 to $20.00. They now have a "buy" rating on the stock.MarketBeat
- OptimizeRx (OPRX) had its price target lowered by Roth Mkm from $32.00 to $18.00. They now have a "buy" rating on the stock.MarketBeat
OPRX
Earnings
- 3/5/26 - Beat
OPRX
Sec Filings
- 3/12/26 - Form 10-K
- 3/5/26 - Form 8-K
- 2/13/26 - Form 4
- OPRX's page on the SEC website